Isfahan University of Medical Sciences

Science Communicator Platform

Share By
Intravenous Drug Use and Hepatitis C Virus in Iran Publisher



Zobeiri M1 ; Adibi P2 ; Alavian SM3
Authors

Source: Hepatitis Monthly Published:2012


Abstract

[No abstract available]
Related Docs
View other Related Docs
1. Intravenous Drug Use and Hepatitis C Virus in Iran, Hepatitis Monthly (2012)
2. Identification of Patients With Hepatitis C Virus Infection in Persons With Background of Intravenous Drug Use: The First Community Announcementbased Study From Iran, International Journal of Preventive Medicine (2012)
3. Isolation of Hepatitis C Virus in Norjizac Vials, Hepatitis Monthly (2010)
Experts (# of related papers)
View all Related Experts
Peyman Adibi (8)
Nazila Kassaian (7)
Other Related Docs
4. Seroprevalence of Hepatitis B Markers Among Incarcerated Intravenous Drug Users, Journal of Research in Medical Sciences (2014)
5. The Experience of Hepatitis C Screening Among Prison Inmates With Drug Injection History, Journal of Isfahan Medical School (2011)
6. Hepatitis C in Intravenous Drug Users: Seroprevalence and Risk Factors, Journal of Isfahan Medical School (2011)
7. Hepatitis C Among Intravenous Drug Users in Isfahan, Iran: A Study of Seroprevalence and Risk Factors, International Journal of Preventive Medicine (2012)
8. Hepatitis C Virus in Iran: Epidemiology of an Emerging Infection, Archives of Iranian Medicine (2005)
9. Incarceration Is a Major Risk Factor for Blood-Borne Infection Among Intravenous Drug Users, Hepatitis Monthly (2011)
10. Hepatitis C Seroprevalence Among Intravenous Drug Users in Tehran, Journal of Research in Medical Sciences (2008)
11. Hepatitis C Virus and Associated Risk Factors Among Prison Inmates With History of Drug Injection in Isfahan, Iran, International Journal of Preventive Medicine (2012)